LHN - Stock Analyst Research

Target Price*SGD 0.39
Recommendation BUY
Market Cap*-
Publication Date13 Dec 2023

*At the time of publication

LHN Ltd – Co-living revenue doubles

  • 2023 revenue was within expectations, but earnings were below expectations. Revenue and adjusted PATMI were 98%/90% of our FY23e forecasts (excluding logistics). 2H23 adjusted PBT was 5% YoY lower due to reduced sublease gains in the commercial segment. 
  • Co-living revenue and earnings jumped an estimated 115% and 97% YoY, respectively in 2H23. A special dividend of 1 cent was announced from the S$18.1mn gain from the disposal of LHN Logistics. Bulk of the proceeds will be redeployed to expand the co-living franchise in Singapore with a target of 800 keys p.a. for three years (or 30% CAGR).
  • We lower our FY24e earnings by 24% following the disposal of LHN Logistics. Consequently, our target price is reduced from S$0.47 to S$0.39. We peg our valuations to 6.5x FY24e P/E, while the industry is trading around 13x. Growth for LHN in FY24e will be driven by the Coliwoo expansion of 347 keys in the pipeline in Singapore and potential overseas expansion. FY25e earnings will be supported by a food factory development project worth an estimated S$70mn. We maintain BUY. LHN is scaling up its co-living franchise and brand name in Singapore. The stock pays a dividend yield of 6%, and trades at a 39% discount-to-book value of S$0.53. 




The Positive

+ Strong growth in co-living. Co-living revenue more than doubled to S$17.8mn. Growth was driven by the new 411 key Coliwoo Orchard, launched in Feb 23. Room rates have been rising for Coliwoo and occupancy remains high at 94.7%. We expect 1H24 growth will be driven by Coliwoo Orchard and additional new projects, 404 Pasir Panjang (63 keys) and 48 & 50 Arab Street (26 keys). Both assets will be operational in 2Q24.


The Negative

– Lumpy commercial earnings. 2H23 PBT for commercial declined significantly due to lower gains from sublease. Such gains are lumpy and represent the fair value of the remaining lease of the asset once tenanted. Commercial recognised a S$5.8mn upfront gain in FY22, based on pre-IFRS 16 reconciliation.



We expect another year of growth for LHN in FY24e

  1. Residential: Co-living growth will stem from 411 Coliwoo Orchard contribution in 1H24, an additional 347 new keys (Figure 1) and firm rental rates in Singapore
  2. Facilities management: Growth in car park usage and new locations will be a driver to revenue. LHN currently manages 80 car parks (including 1 in Hong Kong), with over 26,000 parking lots.
  3. Industrial: Supply is tight due to difficulty in obtaining approval to sublet space. LHN’s work plus store concept catering to small and medium e-commerce operators will enjoy healthier demand.
  4. New areas: Other potential growth opportunities include co-living projects around the region and management of healthcare dorms.


The sale of 49 units of the food factory development project in 55 Tuas South Ave 1 will be the major engine for earnings growth in FY25e. Our forecast does not incorporate these development earnings.



Maintain BUY with lower TP of S$0.39 (prev. S$0.47)

We maintain a BUY with a lower TP of S$0.39. Our valuations are pegged to 6.5x FY24e P/E, while the industry is trading around 13x. LHN is trading at 5x PE and a 39% discount to book value of S$0.53.

About the author

Paul Chew
Head of Research
Phillip Securities Research Pte Ltd

Paul has 20 years of experience as a fund manager and sell-side analyst. During his time as fund manager, he has managed multiple funds and mandates including capital guaranteed, dividend income, renewable energy, single country and regionally focused funds.

He graduated from Monash University and had completed both his Chartered Financial Analyst and Australian CPA programme.

Latest Reports

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com